Author:
Zohlnhöfer D.,Kastrati A.
Publisher
Springer Berlin Heidelberg
Reference62 articles.
1. Ahmad F (2003) The molecular genetics of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Clin Invest Med 264:167–178
2. Anan R, Greve G, Thierfelder L et al. (1994) Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophie cardiomyopathy. J Clin Invest 93:280–285
3. Bauters C, Amouyel P (1998) Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis. Eur Heart J 19(Suppl J):24–29
4. Blair E, Redwood C, Ashrafian H et al. (2001) Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 10:1215–1220
5. Bolhuis PA, Hensels GW, Hulsebos TJ et al. (1991 ) Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome) to Xq28. Am J Hum Genet 48: 481–485